Last reviewed · How we verify

NCT05539716: MaST

Metabolism and Sleep Apnea Treatment

Recruiting now NA Last updated 23 March 2026
What this trial tests

NA trial testing PAP Therapy in Obstructive Sleep Apnea in 100 participants. Currently enrolling.

Timeline
20 May 2022
Primary endpoint
1 June 2027
1 September 2027

Quick facts

Lead sponsorUniversity of Miami
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment100
Start date20 May 2022
Primary completion1 June 2027
Estimated completion1 September 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Miami

Who can join

Adults 18 to 70, any sex, with Obstructive Sleep Apnea or Fat Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to see if obstructive sleep apnea (OSA) is associated with abnormalities in fat metabolism. Through this research study, the Investigator will evaluate how fat is metabolized in people with and without sleep apnea, what substances the fat tissue releases, and how these substances might change the way the body uses energy and sugar.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Obstructive Sleep Apnea

Currently open trials in the same condition.

Other University of Miami trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05539716.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing